Journal of Oral Medicine and Pain

Korean Academy of Orofacial Pain and Oral Medicine (대한안면통증구강내과학회)
권호 표지
DOI QR코드

DOI QR Code

Oral Hairy Leukoplakia in Patient with Human Immunodeficiency Virus Infection

  • Park, Gunwoo (Department of Orofacial Pain and Oral Medicine, Dental Hospital, Yonsei University College of Dentisty) ;
  • Ahn, Hyung Joon (Department of Orofacial Pain and Oral Medicine, Dental Hospital, Yonsei University College of Dentisty) ;
  • Choi, Jong-Hoon (Department of Orofacial Pain and Oral Medicine, Dental Hospital, Yonsei University College of Dentisty) ;
  • Kwon, Jeong-Seung (Department of Orofacial Pain and Oral Medicine, Dental Hospital, Yonsei University College of Dentisty)
  • Received : 2015.03.23
  • Accepted : 2015.04.17
  • Published : 2015.06.30
Download PDF
⟨ Previous Next ⟩

Abstract

Oral hairy leukoplakia occurs on the lateral surface of the tongue that clinically as an asymptomatic white lesion. It is mainly found in patient with human immunodeficiency virus infection. However, it rarely outbreak immunosuppressed patients after organ transplantation, or the patients taking steroids or immunosuppressants. It is the result of proliferating Epstein-Barr virus in the oral epithelium. Most of human immunodeficiency virus infected patients with oral hairy leukoplakia are highly contagious and possible to progress acquired immunodeficiency syndrome. Therefore, the early diagnosis of oral hairy leukoplakia is very important. Taking a thorough history and human immunodeficiency virus screening test is highly recommended in case oral hairy leukoplakia is detected. In this case, a 29-year-old man presented with whitish lesion on lateral border of tongue is diagnosed as oral hairy leukoplakia and human immunodeficiency virus infection.

Keywords

References

  1. Greenspan D, Greenspan JS, Conant M, Petersen V, Silverman S Jr, de Souza Y. Oral “hairy” leucoplakia in male homosexuals: evidence of association with both papillomavirus and a herpes-group virus. Lancet 1984;2:831-834.
  2. Mendoza N, Diamantis M, Arora A, et al. Mucocutaneous manifestations of Epstein-Barr virus infection. Am J Clin Dermatol 2008;9:295-305. https://doi.org/10.2165/00128071-200809050-00003
  3. Pedreira EN, Cardoso CL, Barroso Edo C, Santos JA, Fonseca FP, Taveira LA. Epidemiological and oral manifestations of HIVpositive patients in a specialized service in Brazil. J Appl Oral Sci 2008;16:369-375. https://doi.org/10.1590/S1678-77572008000600003
  4. Greenspan JS, Greenspan D. Oral hairy leukoplakia: diagnosis and management. Oral Surg Oral Med Oral Pathol 1989;67:396-403. https://doi.org/10.1016/0030-4220(89)90381-2
  5. Bhandarkar SS, MacKelfresh J, Fried L, Arbiser JL. Targeted therapy of oral hairy leukoplakia with gentian violet. J Am Acad Dermatol 2008;58:711-712. https://doi.org/10.1016/j.jaad.2007.11.017
  6. Moura MD, Haddad JP, Senna MI, Ferreira e Ferreira E, Mesquita RA. A new topical treatment protocol for oral hairy leukoplakia. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2010;110:611-617. https://doi.org/10.1016/j.tripleo.2010.05.015
  7. Moura MD, Guimaraes TR, Fonseca LM, de Almeida Pordeus I, Mesquita RA. A random clinical trial study to assess the efficiency of topical applications of podophyllin resin (25%) versus podophyllin resin (25%) together with acyclovir cream (5%) in the treatment of oral hairy leukoplakia. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2007;103:64-71. https://doi.org/10.1016/j.tripleo.2006.02.016
  8. Galvin S, Healy CM. Oral hairy leukoplakia in healthy, immunocompetent individuals. Ir Med J 2014;107:179-180.
  9. Reynolds SJ, Muwonga J. OraQuick ADVANCE rapid HIV-1/2 antibody test. Expert Rev Mol Diagn 2004;4:587-591. https://doi.org/10.1586/14737159.4.5.587
  10. Zachary D, Mwenge L, Muyoyeta M, et al. Field comparison of OraQuick ADVANCE rapid HIV-1/2 antibody test and two blood-based rapid HIV antibody tests in Zambia. BMC Infect Dis 2012;12:183. https://doi.org/10.1186/1471-2334-12-183
  11. Delaney KP, Branson BM, Uniyal A, et al. Performance of an oral fluid rapid HIV-1/2 test: experience from four CDC studies. AIDS 2006;20:1655-1660. https://doi.org/10.1097/01.aids.0000238412.75324.82
  12. Wesolowski LG, MacKellar DA, Facente SN, et al; Post-marketing Surveillance Team. Post-marketing surveillance of OraQuick whole blood and oral fluid rapid HIV testing. AIDS 2006;20:1661-1666. https://doi.org/10.1097/01.aids.0000238413.13442.ed
  13. Baccaglini L, Atkinson JC, Patton LL, Glick M, Ficarra G, Peterson DE. Management of oral lesions in HIV-positive patients. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2007;103 Suppl:S50.e1-S50.e23.
  14. Gowdey G, Lee RK, Carpenter WM. Treatment of HIV-related hairy leukoplakia with podophyllum resin 25% solution. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1995;79:64-67. https://doi.org/10.1016/S1079-2104(05)80076-9
  15. Sanchez M, Spielman T, Epstein W, Moy J. Treatment of oral hairy leukoplakia with podophyllin. Arch Dermatol 1992;128:1659. https://doi.org/10.1001/archderm.1992.04530010095028
  16. Brasileiro CB, Abreu MH, Mesquita RA. Critical review of topical management of oral hairy leukoplakia. World J Clin Cases 2014;2:253-256. https://doi.org/10.12998/wjcc.v2.i7.253